MDM2 and fatty liver disease: It was more interesting that Mdm2-AKI mice on a HFD exhibited exacerbated eWAT dysfunction, such as increased cellular senescence, apoptosis, and inflammation, thereby aggravating HFD-induced hepatic steatosis and insulin resistance.